Boardroom Alpha
SC 13D/A primary document
GNK · Amended Beneficial Ownership Report (Schedule 13D/A) · Filed June 30, 2026

Genco Shipping & Trading LtdSC 13D/A exhibit

tm2619439d1_ex-b2.htm

Exhibit (b)(2)

 
 

 
 

 

Very truly yours,

 

 

 

DNB (UK) LIMITED

 

 

 

By: /s/ Harry Leadsom                  /s/ Kelly Kouros                 
Name: Harry Leadsom Kelly Kouros
Title: Authorised Signatory Authorised Signatory

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

DNB BANK ASA

 

 

 

By: /s/ Harry Leadsom                  /s/ Kelly Kouros                 
Name: Harry Leadsom Kelly Kouros
Title: Authorised Signatory Authorised Signatory

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

DNB BANK ASA, LONDON BRANCH

 

 

 

By: /s/ Harry Leadsom                  /s/ Kelly Kouros                 
Name: Harry Leadsom Kelly Kouros
Title: Authorised Signatory Authorised Signatory

 

 

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

NORDEA BANK ABP NUF

 

 

 

By: /s/ Jan-Olay Egge              

 

Name: Jan-Olay Egge

 

Title: Director

 

 

 

By: /s/ Henrik Trulsen              

 

Name: Henrik Trulsen

 

Title: Director

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

BNP PARIBAS S.A.

 

 

 

By: /s/ Mathieu Vidal              

 

Name: Mathieu Vidal

 

Title: Director

 

 

 

By: /s/ Pierre Frachon              

 

Name: Pierre Frachon

 

Title: Managing Director

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

DANSKE BANK A/S

 

 

 

By: /s/ Einar Stavrum              

 

Name: Einar Stavrum

 

Title: Senior Vice President

 

 

 

By: /s/ Tom Erik Vigen              

 

Name: Tom Erik Vigen

 

Title: Senior Vice President

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

DEUTSCHE BANK AG

 

 

 

By: /s/ Ilias Katsoulis              

 

Name: Ilias Katsoulis

 

Title: Authorised Signatory

 

 

 

By: /s/ Karina Harper              

 

Name: Karina Harper

 

Title: Authorised Signatory

 

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

STANDARD CHARTERED BANK

 

 

 

By: /s/ Gaurav Moolwaney              

 

Name: Gaurav Moolwaney

 

Title: Managing Director, Transportation Finance

 

 

 

 

 

[Signature Page to Amendment Letter]

 

 

Accepted and agreed by:

  

DIANA SHIPPING INC.

 

 

 

By: /s/ Ioannis Zafirakis              

 

Name: Ioannis Zafirakis

 

Title: Director and President

 

Date: June 30, 2026

 

 

 

 

 

 

 

 

[Signature Page to Amendment Letter]

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer